Samsung BioLogics and Biogen: Who Had Control?
The controversy surrounding Samsung Biologics Co., Ltd (207940 KS) 's booking of a fair value gain in 2015 relates to their claim of a "loss of...
473 Views
Samsung Biologics' Accounting Violation's Impact on Samsung C&T and Rest of the Korean Pharmas
On May 1st, 2018, Korea's Financial Supervisory Service (FSS) announced that Samsung Biologics Co., Ltd (207940 KS) violated accounting rules after...
309 Views
All Roads Lead to Samsung C&T
The margin of safety in Samsung C&T Corp (028260 KS) has become a lot more attractive versus one or two years ago. In this report, we...
386 Views
A Conversation with Biogen
Biogen Inc (BIIB US) is Samsung Biologics Co., Ltd (207940 KS) 's minority (5.4%) partner in the Samsung Bioepis JV that manufactures and sells...
437 Views
Binex - Paving the Way for Next-Gen Biotech Breakthrough
We met with Mr. HJ Lee, CEO & President of Binex, followed by a quick site tour in Incheon, Korea, and learned that the company has recently...
443 Views